An Open-labelled, Multicentered, Follow-up Study for a Phase III, Efficacy Trial to Evaluate the Two-year Efficacy, Safety, and Immune Persisitence of Inactivated Enterovirus Type 71 (EV71) Vaccine
Latest Information Update: 30 May 2022
Price :
$35 *
At a glance
- Drugs Enterovirus A vaccine (Primary)
- Indications Coxsackievirus infections; Enterovirus A infections
- Focus Therapeutic Use
- Sponsors Sinovac Biotech
- 21 May 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 10 Dec 2013 New trial record